Randomized Trial of Thrombolysis Versus Heparin in Unstable Angina

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Circulation

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.86.5.1407PMID 1423953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• Thrombolysis in unstable angina.

  1992cited by this paper
• In Vitro Effect of Plasmin on Human Platelet Function in Plasma: Inhibition of Aggregation Caused by Fibrinogenolysis

  1992cited by this paper
• Thrombolysis in Unstable Angina: Randomized Double‐Blind Trial of t‐PA and Placebo

  1992cited by this paper
• Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes.

  1992cited by this paper
• Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina.

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• [Thrombolysis in unstable angina].

  1991cited by this paper
• Thrombolysis in refractory unstable angina.

  1991cited by this paper
• Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group.

  1991cited by this paper
• Catheterization/rescue angioplasty following thrombolysis (craft) study: Acute myocardial infarction treated with recombinant tissue plasminogen activator versus urokinase

  1991cited by this paper
• Effect of heparin, aspirin, or alteplase in reduction of myocardial ischemia in refractory unstable angina

  1990cited by this paper
• Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris.

  1990cited by this paper
• Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.

  1990cited by this paper
• Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.

  1990cited by this paper
• Intravenous streptokinase in the management of a subset of patients with unstable angina: a randomized controlled trial.

  1990cited by this paper
• Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease

  1990cited by this paper
• Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group.

  1990cited by this paper
• Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events.

  1989cited by this paper
• Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

  1989cited by this paper
• Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.

  1989cited by this paper
• Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina.

  1989cited by this paper
• Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.

  1988cited by this paper
• The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks.

  1988cited by this paper
• EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL

  1988cited by this paper
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)

  1988cited by this paper
• Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  1988cited by this paper
• Streptokinase and reduced plasma viscosity: A second benefit

  1988cited by this paper
• Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).

  1988cited by this paper
• Aspirin, heparin, or both to treat acute unstable angina.

  1988cited by this paper
• Effects of thrombolytic therapy in unstable angina: clinical and angiographic results.

  1988cited by this paper
• A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.

  1987cited by this paper
• Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction.

  1987cited by this paper
• Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.

  1985cited by this paper
• Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris.

  1983cited by this paper
• Intracoronary thrombolysis in syndromes of unstable ischemia: angiographic and clinical results.

  1982cited by this paper
• Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.

  1981cited by this paper
• Fibrinolytic therapy in unstable angina pectoris. A controlled clinical trial.

  1980cited by this paper
• A multiple testing procedure for clinical trials.

  1979cited by this paper
• The urokinase pulmonary embolism trial. A national cooperative study.

  1973cited by this paper

• Physicochemical Characteristics of Cardiological Drugs and Practical Recommendations for Intravenous Administration: A Systematic Review

  2025cites this paper
• Antiplatelet agents and anticoagulants for hypertension.

  2022cites this paper
• Antithrombotic therapy in the early phase of NSTE-ACS: a systematic review and meta-analysis.

  2019cites this paper
• Explorer Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome

  2017cites this paper
• Sulfotanshinone Sodium Injection for Unstable Angina Pectoris: A Systematic Review of Randomized Controlled Trials

  2012cites this paper
• Antiplatelet agents and anticoagulants for hypertension.

  2011cites this paper
• Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome.

  2009cites this paper
• Rokowanie w zawale serca z uniesieniem i bez uniesienia odcinka ST. Czy nadszedł już czas na zmianę wytycznych

  2009cites this paper
• Czy w erze terapii inwazyjnej zawał serca bez uniesienia odcinka ST powinno się leczyć inaczej niż zawał serca z uniesieniem odcinka ST

  2008cites this paper
• Unstable angina and non-ST-segment myocardial infarction: an evidence-based approach to management.

  2006cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial

  2005cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial The TIMI IIIB

  2005cites this paper
• Recombinant Hirudin for Unstable Angina Pectoris

  2005cites this paper
• Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction

  2005cites this paper
• A Multicenter, Randomized Angiographic Trial

  2005cites this paper
• Antithrombotic therapy in hypertension: a Cochrane Systematic review

  2005cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial

  2005cites this paper
• Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction

  2005cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial

  2005cites this paper
• Unstable angina and non-ST-segment elevation myocardial infarction: part I. Initial evaluation and management, and hospital care.

  2004cites this paper
• Differences Between Unstable Angina and Acute Myocardial Infarction: Pathophysiological and Clinical Spectrum

  2004cites this paper
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  2002cites this paper
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2002cites this paper
• Unstable angina pectoris and non-Q-wave myocardial infarction.

  2001cites this paper
• A time-to-treatment analysis in the medicine versus angiography in thrombolytic exclusion (MATE) trial.

  2001cites this paper
• Antithrombotic therapy in patients with acute coronary syndromes.

  2001cites this paper
• Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation.

  2001cites this paper
• Impaired Culprit Vessel Flow in Acute Coronary Syndromes Ineligible for Thrombolysis

  2000cites this paper
• ["Inappropriate" thrombolysis in suspected myocardial infarct].

  2000cites this paper
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology

  2000cites this paper
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

  2000cites this paper
• Randomized Clinical Trial of Urokinase versus Heparin in Unstable Angina

  1999cites this paper
• Frhe versus spte Intervention beim akuten Koronarsysndrom: Argumente aus klinischer Sicht

  1999cites this paper
• Early use of coronary angiography and intervention.

  1999cites this paper
• GLYCOPROTEIN IIB/IIIA ANTAGONISTS: DO THEY HAVE A ROLE IN THE MANAGEMENT OF UNSTABLE ANGINA?

  1999cites this paper
• Unstable Angina Pectoris

  1998cites this paper
• CK-MB Measurements by Immunoassay

  1998cites this paper
• A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial.

  1998cites this paper
• Elderly patients receive less aggressive medical and invasive management of unstable angina: potential impact of practice guidelines.

  1998cites this paper
• Acute coronary syndromes.

  1997cites this paper
• Progress in interventional cardiology.

  1997cites this paper
• Thrombolysis and modern anticoagulation in unstable angina pectoris

  1997cites this paper
• Con: thoracic epidural anesthesia is not indicated in the treatment of unstable angina.

  1997cites this paper
• Comparison of the histopathology of culprit lesions in chronic stable angina, unstable angina, and myocardial infarction

  1997cites this paper
• [Current aspects of thrombolytic therapy in unstable angina pectoris].

  1997cites this paper
• [Symptomatic therapy refractory myocardial ischemia in coronary heart disease. Chronic intermittent urokinase therapy and invasive therapeutic measures].

  1996cites this paper
• Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies.

  1996cites this paper
• Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial.

  1996cites this paper
• Prolonged streptokinase infusion in patients with unstable angina: results of a randomized, placebo-controlled clinical trial.

  1996cites this paper
• -New perspectives in therapy of unstable angina-.

  1996cites this paper
• Use of urokinase in unstable angina.

  1996cites this paper
• Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin.

  1996cites this paper
• Chronic‐intermittent urokinase therapy in patients with end‐stage coronary artery disease and refractory angina pectoris—A pilot study

  1996cites this paper
• [Thrombolytic therapy in arterial disorders other than myocardial infarction].

  1996cites this paper
• Pharmacological Properties of Hirudin and its Derivatives

  1996cites this paper
• Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes.

  1995cites this paper
• Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents.

  1995cites this paper
• Intravenous thrombolysis in refractory unstable angina pectoris.

  1995cites this paper
• Thrombolysis plus heparin versus heparin alone in the acute phases of unstable angina: preliminary findings

  1995cites this paper
• Antithrombotic and thrombolytic therapy in patients undergoing coronary artery interventions: a review.

  1995cites this paper
• One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.

  1995cites this paper
• Evaluation of thrombolytic and monoclonal platelet GPIIb/IIIa receptor antibody therapy in refractory unstable angina pectoris: correlation between quantitative assessment of coronary angiograms and clinical course

  1994cites this paper
• Challenge of Thrombolytic Therapy in Unstable Angina Pectoris

  1994cites this paper
• Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty.

  1994cites this paper
• Thrombolysis for arterial conditions other than myocardial infarction.

  1994cites this paper
• Correlation between clinical course and quantitative analysis of the ischemia related artery in patients with unstable angina pectoris, refractory to medical treatment

  1994cites this paper
• Correlation between clinical course and quantitative analysis of the ischemia related artery in patients with unstable angina pectoris, refractory to medical treatment. Results of two randomized trials. The European Cooperative Study Group.

  1994cites this paper
• Practical guide for drug administration by intravenous infusion in intensive care units

  1994cites this paper
• Acute Coronary Syndromes: Focus on Unstable Angina

  1994cites this paper
• Effects of Antithrombotic Agents on Mortality and Nonfatal Cardiac Events

  1994cites this paper
• Unstable angina: Prognosis, noninvasive risk assessment, and strategies for management

  1994cites this paper
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994

  1994cites this paper
• Emergency Medicine

  1994cites this paper
• [Possibilities and limitations of thrombolysis. Benefits and risk in acute myocardial infarct, lung embolism, pelvic and leg vein thrombosis as well as cerebrovascular accidents].

  1994cites this paper
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

  1994cites this paper
• Intravenous diltiazem versus isosorbide dinitrate for unstable angina: comparison of coronary angiographic morphology in the unstable and stabilized states

  1994cites this paper
• Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.

  1994cites this paper
• Progress in interventional cardiology.

  1993cites this paper
• Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris.

  1993cites this paper
• Thrombolysis in unstable angina.

  1993cites this paper
• Angioscopy, coronary thrombi and acute coronary syndromes.

  1993cites this paper
• Recombinant tissue type plasminogen activator and heparin in acute angina at rest

  1993cites this paper
• UROKINASE VS. HEPARIN FOR UNSTABLE ANGINA.

  1992cites this paper
• Is thrombolytic therapy striking out in unstable angina?

  1992cites this paper